Chad M Robins Adaptive Biotechnologies Corp (ADPT) insider trading activity

ADPT Quotes by TradingView

Chad M Robins is CEO and Chairman of Adaptive Biotechnologies Corp. Currently has a direct ownership of 2.96 Million shares of ADPT, which is worth approximately $24.9 Million. The most recent transaction as insider was on Dec 28, 2020, when has been sold 16,250 shares (Common Stock) at a price of $62.05 per share, resulting in proceeds of $1,008,312. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 2.96M
14.85% 3M change
14.85% 12M change
Total Value Held $24.9 Million

CHAD M ROBINS Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 28 2020
SELL
Open market or private sale
$1,008,312 $62.05 p/Share
16,250 Reduced 0.91%
1,778,180 Common Stock
Dec 28 2020
BUY
Exercise of conversion of derivative security
$5,363 $0.33 p/Share
16,250 Added 0.9%
1,794,430 Common Stock
Nov 19 2020
SELL
Open market or private sale
$786,462 $47.15 p/Share
16,680 Reduced 0.93%
1,778,180 Common Stock
Nov 19 2020
BUY
Exercise of conversion of derivative security
$5,504 $0.33 p/Share
16,680 Added 0.92%
1,794,860 Common Stock
Nov 18 2020
SELL
Open market or private sale
$794,135 $47.61 p/Share
16,680 Reduced 0.93%
1,778,180 Common Stock
Nov 18 2020
BUY
Exercise of conversion of derivative security
$5,504 $0.33 p/Share
16,680 Added 0.92%
1,794,860 Common Stock
Nov 17 2020
SELL
Open market or private sale
$771,617 $46.26 p/Share
16,680 Reduced 0.93%
1,778,180 Common Stock
Nov 17 2020
BUY
Exercise of conversion of derivative security
$5,504 $0.33 p/Share
16,680 Added 0.92%
1,794,860 Common Stock
Oct 08 2020
SELL
Open market or private sale
$1,236,532 $50.97 p/Share
24,260 Reduced 1.35%
1,778,180 Common Stock
Oct 08 2020
BUY
Exercise of conversion of derivative security
$8,006 $0.33 p/Share
24,260 Added 1.33%
1,802,440 Common Stock
Oct 07 2020
SELL
Open market or private sale
$2,490,000 $49.8 p/Share
50,000 Reduced 2.73%
1,778,180 Common Stock
Oct 07 2020
BUY
Exercise of conversion of derivative security
$16,500 $0.33 p/Share
50,000 Added 2.66%
1,828,180 Common Stock
Oct 06 2020
SELL
Open market or private sale
$903,215 $49.41 p/Share
18,280 Reduced 1.02%
1,778,180 Common Stock
Oct 06 2020
BUY
Exercise of conversion of derivative security
$6,032 $0.33 p/Share
18,280 Added 1.01%
1,796,460 Common Stock
Oct 01 2020
SELL
Open market or private sale
$30,030 $50.05 p/Share
600 Reduced 0.03%
1,778,180 Common Stock
Oct 01 2020
BUY
Exercise of conversion of derivative security
$198 $0.33 p/Share
600 Added 0.03%
1,778,780 Common Stock
Sep 29 2020
SELL
Open market or private sale
$95,342 $50.18 p/Share
1,900 Reduced 0.11%
1,778,180 Common Stock
Sep 29 2020
BUY
Exercise of conversion of derivative security
$627 $0.33 p/Share
1,900 Added 0.11%
1,780,080 Common Stock
CMR

Chad M Robins

CEO and Chairman
Seattle, WA

Track Institutional and Insider Activities on ADPT

Follow Adaptive Biotechnologies Corp and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ADPT shares.

Notify only if

Insider Trading

Get notified when an Adaptive Biotechnologies Corp insider buys or sells ADPT shares.

Notify only if

News

Receive news related to Adaptive Biotechnologies Corp

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ADPT